Sydney Jennings

Articles

A Comprehensive Approach to Obesity Treatment: Combining Lifestyle, Medication, and Surgery

April 16, 2025

ACP 2025: GLP-1 medications are advancing obesity care, but lifestyle changes and bariatric surgery remain key components. Laura Davisson, MD, discusses how to personalize treatment strategies.

New Insights Into Treatment Resistant Depression Show Gaps in Care: Daily Dose

April 16, 2025

Your daily dose of the clinical news you may have missed.

Matthew Press, MD: How Penn Medicine’s CoCM Model Helps PCPs Treat Mental Health—and Avoid Burnout

April 15, 2025

ACP 2025: Dr Press discusses how the Penn Integrated Care model equips primary care physicians to manage mental health conditions more effectively while reducing burnout.

Oral Gepotidacin Noninferior to Standard Therapy for Gonorrhea in Phase 3 Trial

April 15, 2025

Data from the EAGLE-1 study found gepotidacin to be noninferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.

Study Links CV Mortality Rise to Maternal Health Disparities: Daily Dose

April 15, 2025

Your daily dose of the clinical news you may have missed.

FDA, Novo Nordisk Investigating Counterfeit Semaglutide Injection in US Supply Chain

April 14, 2025

The FDA and Novo Nordisk are urging health care professionals to check semaglutide (Ozempic) injection 1 mg lot PAR0362 with serials starting 51746517.

Rethinking Lung Cancer Screening: Expanding Access for Women, Nonsmokers

April 14, 2025

ACP 2025: Lung cancer is rising among nonsmokers, especially women. Kim Sandler, MD, discusses future screening challenges, research insights, and the need to expand screening eligibility.

AGA Issues Guideline on AI Technology in Colonoscopy: Daily Dose

April 14, 2025

Your daily dose of the clinical news you may have missed.

Collaborative Care for Mental Health: A Scalable, Team-Based Model for Primary Care

April 11, 2025

ACP 2025: Discover how the collaborative care model supports mental health in primary care through team-based care, symptom tracking, and psychiatric consultation—boosting outcomes and reducing burden on clinicians.

Tirzepatide Improves Heart Failure Symptoms and Renal Function in People with Obesity, CKD

April 11, 2025

ACC 2025. Tirzepatide improved HF symptoms and renal function in patients with obesity-related HFpEF, regardless of CKD status, according to new findings from the SUMMIT trial.